A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Campbell, Katrina L ^a,b,c   Johnson, David W ^a,b,c   Bauer, Judith D ^b   Hawley, Carmel M ^a,b,c   Isbel, Nicole M ^a,b,c   Stowasser, Michael ^a,b,c   Whitehead, Jonathan P ^b,c   Dimeski, Goce ^a,b   McMahon, Emma ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

Author keywords

Blood pressure; Cardiovascular disease; Chronic kidney disease; Dietary sodium; Inflammation; Kidney function; Nutrition

Indexed keywords

ADIPONECTIN; ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; GAMMA INTERFERON; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; ANALYSIS; ARTICLE; BLOOD PRESSURE; BODY FLUID; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; MOLECULAR WEIGHT; POST HOC ANALYSIS; PROTEINURIA; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SODIUM EXCRETION; SODIUM RESTRICTION; BLOOD; DIET THERAPY; DOUBLE BLIND PROCEDURE; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADIPOKINES; AGED; BODY FLUIDS; CREATININE; DIET, SODIUM-RESTRICTED; DOUBLE-BLIND METHOD; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84899486294     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-57     Document Type: Article

References (31)

1. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G, J Am Soc Nephrol 2008 19 5 999 1007 10.1681/ASN.2007060693 18272844
2. A Randomized Trial of Dietary Sodium Restriction in CKD. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Campbell KL, J Am Soc Nephrol 2013 24 12 2096 2103 10.1681/ASN.2013030285 24204003
3. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM, Circulation 2001 103 7 987 992 10.1161/01.CIR.103.7.987 11181474
4. Effect of lower sodium intake on health: systematic review and meta-analyses. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ, BMJ 2013 346 1326 10.1136/bmj.f1326 23558163
5. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. Strazzullo P, D'Elia L, Kandala N-B, Cappuccio FP, BMJ 2009 339 4567 10.1136/bmj.b4567 19934192
6. Mechanisms and consequences of salt sensitivity and dietary salt intake. Kanbay M, Chen Y, Solak Y, Sanders PW, Curr Opin Nephrol Hypertens 2011 20 1 37 43 10.1097/MNH.0b013e32834122f1 21088577
7. Salt and Hypertension: Is Salt Dietary Reduction Worth the Effort? Frisoli TM, Schmieder RE, Grodzicki T, Messerli FH, Am J Med 2012 125 5 433 439 10.1016/j.amjmed.2011.10.023 22482843
8. Is higher sodium intake associated with elevated systemic inflammation? A population-based study. Fogarty AW, Lewis SA, McKeever TM, Britton JR, Am J Clin Nutr 2009 89 6 1901 1904 10.3945/ajcn.2008.27006 19386745
9. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. Lely AT, Krikken JA, Bakker SJ, Boomsma F, Dullaart RP, Wolffenbuttel BH, Navis G, J Clin Endocrinol Metab 2007 92 5 1821 1826 10.1210/jc.2006-2092 17341566
10. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Koomans HA, Roos JC, Boer P, Geyskes GG, Mees EJ, Hypertension 1982 4 2 190 197 10.1161/01.HYP.4.2.190 7040224
11. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease. Essig M, Escoubet B, de Zuttere D, Blanchet F, Arnoult F, Dupuis E, Michel C, Mignon F, Mentre F, Clerici C, Vrtovsnik F, Nephrol Dial Transplant 2008 23 1 239 248 17704109
12. Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients. Slagman MCJ, Waanders F, Vogt L, Damman K, Hemmelder M, Navis G, Laverman GD, Nephrol Dial Transplant 2012 27 3 983 990 10.1093/ndt/gfr408 21862455
13. The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): Protocol of a randomized trial. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Hale RE, Campbell KL, BMC Nephrology 2012 13 1 137 10.1186/1471-2369-13-137 23082956
14. Validation and comparison of two multiplex technologies, Luminex® and Mesoscale Discovery, for human cytokine profiling. Chowdhury F, Williams A, Johnson P, J Immunol Methods 2009 340 1 55 64 18983846
15. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C, Hu B, Greene T, Appel L, Phillips RA, African American Study of Kidney Disease, Hypertension Collaborative Research Group, Hypertension 2009 53 1 20 27 10.1161/HYPERTENSIONAHA.108.115154 19047584
16. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E, Hypertension 2005 46 156 161 10.1161/01.HYP.0000170138.56903.7a 15939805
17. Central blood pressure in the management of hypertension: soon reaching the goal? Sharman JE, Laurent S, J Hum Hypertens 2013 27 7 405 411 10.1038/jhh.2013.23 23535990
18. Central pulse pressure and mortality in end-stage renal disease. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM, Hypertension 2002 39 3 735 738 10.1161/hy0202.098325 11897754
19. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C, Eur Heart J 2010 31 15 1865 1871 10.1093/eurheartj/ehq024 20197424
20. Altered dietary salt intake for preventing and treating diabetic kidney disease. Suckling RJ, He FJ, Macgregor GA, Cochrane Database Syst Rev 2010 12 D006763 21154374
21. Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus. Luik PT, Hoogenberg K, Van Der Kleij FG, Beusekamp BJ, Kerstens MN, De Jong PE, Dullaart RP, Navis GJ, Diabetologia 2002 45 4 535 541 10.1007/s00125-001-0763-8 12032630
22. Does high salt intake cause hyperfiltration in patients with essential hypertension? Mallamaci F, Leonardis D, Bellizzi V, Zoccali C, J Hum Hypertens 1996 10 3 157 161 8733032
23. Increased glomerular filtration rate as a predictor of diabetic nephropathy-an 8-year prospective study. Rudberg S, Persson B, Dahlquist G, Kidney Int 1992 41 4 822 828 10.1038/ki.1992.126 1513104
24. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Mogensen CE, Scand J Clin Lab Invest 1986 46 3 201 206 10.3109/00365518609083660 3715374
25. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Waden J, Tolonen N, Saraheimo M, Gordin D, Groop PH, FinnDiane Study Group, Diabetes Care 2011 34 4 861 866 10.2337/dc10-1722 21307382
26. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, Chen C-S, Chen J, Lu F, Hu D, Rice T, Kelly TN, Hamm LL, Whelton PK, He J, The Lancet 2009 373 9666 829 835 10.1016/S0140-6736(09)60144-6
27. High salt intake fails to enhance plasma adiponectin in normotensive salt-sensitive subjects. Liu F, Mu J, Yuan Z, Wu G, Liu E, Zheng S, Lian Q, Ren K, Xu H, Nutrition (Burbank, Los Angeles County, Calif) 2012 28 4 422 425 10.1016/j.nut.2011.08.018
28. Short term dietary sodium restriction decreases HDL cholesterol, apolipoprotein A-I and high molecular weight adiponectin in healthy young men: relationships with renal hemodynamics and RAAS activation. Krikken JA, Dallinga-Thie GM, Navis G, Dullaart RP, Nutr Metab Cardiovasc Dis 2012 22 1 35 41 10.1016/j.numecd.2010.03.010 20678904
29. Adipose tissue and its relation to inflammation: the role of adipokines. Axelsson J, Heimburger O, Lindholm B, Stenvinkel P, J Ren Nutr 2005 15 1 131 136 10.1053/j.jrn.2004.09.034 15648022
30. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C, Oguz Y, Yavuz I, Vural A, Nephrology (Carlton) 2007 12 2 147 153 10.1111/j.1440-1797.2007.00764.x 17371337
31. Increased levels of atherosclerosis markers in salt-sensitive hypertension. Larrousse M, Bragulat E, Segarra M, Sierra C, Coca A, de La Sierra A, Am J Hypertens 2006 19 1 87 93 10.1016/j.amjhyper.2005.06.019 16461197